Skip to main content

Advertisement

SpringerLink
Log in

18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma

  • Interesting Image
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

We described the clinical impact of 18F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma. We detailed the diagnostic imaging workup focusing our attention on the CT, MR, and 18F-FDG PET/MR different findings. In this case, 18F-FDG PET/MR imaging evaluation resulted not only effective but also altered staging and spared additional invasive procedures in the assessment of a metastatic urethral adenocarcinoma. Combining a highly sensitive PET with the increase tissue resolution of MR (PET/MR) may improve abdominal and pelvic lesion detection outperforming PET/CT for this indication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44:1499–505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tagliabue L, Del Sole A. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients. Eur J Intern Med. 2014;25:6–11.

    Article  PubMed  Google Scholar 

  3. Ha HK, Koo PJ, Kim SJ. Diagnostic accuracy of F-18 FDG PET/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: a systematic review and meta-analysis. Oncology. 2018;95:31–8.

    Article  CAS  PubMed  Google Scholar 

  4. Kitajima K, Yamamoto S, Fukushima K, et al. Update on advances in molecular PET in urological oncology. Jpn J Radiol. 2016;34:470–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845–55.

    Article  PubMed  Google Scholar 

  6. Quick HH, von Gall C, Zeilinger M, et al. Integrated whole-body PET/MR hybrid imaging: clinical experience. Investig Radiol. 2013;48:280–9.

    Article  Google Scholar 

  7. Wehrl HF, Sauter AW, Divine MR, et al. Combined PET/MR: a technology becomes mature. J Nucl Med. 2015;56:165–8.

    Article  CAS  PubMed  Google Scholar 

  8. Xin J, Ma Q, Guo Q, et al. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer. Eur J Radiol. 2016;85:751–9.

    Article  PubMed  Google Scholar 

  9. Schwartz M, Gavane SC, Bou-Ayache J, et al. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study. Abdom Radiol (NY). 2018;43:3462–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical and Dental Sciences and of Morpho-functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy

    Riccardo Laudicella & Sergio Baldari

  2. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, USA

    Guido Davidzon & Andrei Iagaru

  3. Department of Radiology, Stanford University, Stanford, USA

    Shreyas Vasanawala

Authors
  1. Riccardo Laudicella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guido Davidzon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shreyas Vasanawala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sergio Baldari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrei Iagaru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Riccardo Laudicella.

Ethics declarations

Conflict of Interest

Laudicella R., Davidzon G., Vasanawala S., Baldari S., and Iagaru A declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laudicella, R., Davidzon, G., Vasanawala, S. et al. 18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma. Nucl Med Mol Imaging 53, 296–299 (2019). https://doi.org/10.1007/s13139-019-00597-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-019-00597-8

Keywords

Search

Navigation